Published on 10 Nov 2023 on Zacks via Yahoo Finance
Ironwood Pharmaceuticals, Inc. IRWD reported adjusted earnings of 12 cents per share for third-quarter 2023, missing the Zacks Consensus Estimate of 17 cents. The company had reported adjusted earnings of 28 cents per share in the year-ago quarter.
Total revenues in the reported quarter were $113.7 million, beating the Zacks Consensus Estimate of $113 million. The top line also increased almost 4.6% year over year.
Quarter in Detail